Hikari Suzuki

发表

Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.

T. Haruta, I. Usui, M. Ishiki, 2007, Endocrinology.

Angiotensin II enhances the increase in monocyte chemoattractant protein-1 production induced by tumor necrosis factor-{alpha} from 3T3-L1 preadipocytes.

K. Yamazaki, K. Tobe, I. Usui, 2009, The Journal of endocrinology.

Angiotensin II enhances the increa se in monocyte chemoattractant protein-1 production induced by tumor necrosis factor-a from 3 T 3L 1 preadipocytes

K. Yamazaki, K. Tobe, I. Usui, 2009 .

A novel model of insulin‐dependent diabetes with renal and retinal lesions by transgenic expression of CaMKIIα (Thr286Asp) in pancreatic β‐cells

S. Takasawa, H. Okamoto, K. Tobe, 2008, Diabetes/metabolism research and reviews.

Characterization of diabetic nephropathy in CaM kinase IIalpha (Thr286Asp) transgenic mice.

K. Tsuneyama, Y. Tabuchi, I. Takasaki, 2009, Biochemical and biophysical research communications.

Author Correction: A cluster-randomized trial of the effectiveness of a triple-faceted intervention promoting adherence to primary care physician visits by diabetes patients: J-DOIT2 large-scale trial (J-DOIT2-LT)

A. Goto, Y. Hayashino, K. Yamazaki, 2020, Scientific Reports.

A cluster-randomized trial of the effectiveness of a triple-faceted intervention promoting adherence to primary care physician visits by diabetes patients

A. Goto, Y. Hayashino, K. Yamazaki, 2020, Scientific Reports.

Secretory units of islets in transplantation index is a useful predictor of insulin requirement in Japanese type 2 diabetic patients

M. Kigawa, K. Tobe, M. Iwata, 2013, Journal of diabetes investigation.

Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.

K. Tsuneyama, K. Tobe, I. Usui, 2009, American journal of physiology. Endocrinology and metabolism.

Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice.

K. Tsuneyama, Y. Tabuchi, I. Takasaki, 2011, Endocrinology.

Behavioral change stage might moderate the impact of multifaceted interventions on non‐attendance from medical care among patients with type 2 diabetes: The Japan Diabetes Outcome Intervention Trial‐2 Large‐Scale Trial 007 (J‐DOIT2‐LT007)

Y. Hayashino, K. Yamazaki, R. Bouchi, 2023, Journal of diabetes investigation.

Multifaceted intervention to promote the regular visiting of patients with diabetes to primary care physicians: rationale, design and conduct of a cluster-randomized controlled trial. The Japan Diabetes Outcome Intervention Trial-2 study protocol

N. Ishizuka, Y. Hayashino, K. Yamazaki, 2010 .

Employment status and diabetic outpatient appointment non-attendance in middle to senior working generation with type 2 diabetes: the Japan diabetes outcome intervention trial-2 large‑scale trial 005 (J-DOIT2-LT005)

Y. Hayashino, K. Yamazaki, K. Izumi, 2022, Acta Diabetologica.

Deletion of platelet-derived growth factor receptor-β improves diabetic nephropathy in Ca2+/calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic mice

S. Takasawa, H. Okamoto, K. Tobe, 2011, Diabetologia.